Implanted muscle tissue boosts metabolism in aged mice
What if you could slow aging by placing a small piece of muscle tissue under the skin? Researchers did exactly that in mice and saw improvements far beyond the implantation site.
A new study in Nature Aging describes the development of so-called myografts: pieces of muscle tissue grown from an animal’s own cells and then implanted under the skin. The researchers implanted these myografts into aged and obese mice. The myografts developed their own blood vessel network and contracted continuously, similar to active muscle tissue.
Systemic effects beyond the implant site
Notably, the improvements were not limited to the site of implantation. The mice showed systemic effects: better overall muscle function, improved metabolic regulation, and signs of tissue regeneration in other organs. This suggests the myografts release substances that reach other tissues via the bloodstream, though the precise mechanism has not yet been fully clarified.
Muscle cells produce signalling proteins (myokines) during contraction that influence fat burning, insulin sensitivity, and inflammation. The researchers suggest that the continuously contracting myografts deliver a signal similar to regular exercise, even in animals unable to exercise themselves. This remains hypothetical and requires confirmation in follow-up research.
From mice to humans: a long road ahead
The study was conducted in mice and is still at an early stage. Cell and gene therapy for aging are active research fields, but translating findings to clinical use in humans requires extensive safety research. The researchers emphasise that myograft technology could complement existing treatments for age-related muscle loss (sarcopenia), but that no clinical data in humans are yet available.
For now, the findings are encouraging as proof of concept that muscle tissue can function as a kind of biological signalling organ, even after implantation.
Want to research this yourself?
Search for example:
- myokines muscle aging
- autologous cell therapy sarcopenia
- systemic tissue regeneration